| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 673.2K | $1.18M | - | |
| Dir | 112.0K | $196.0K | - | |
| Dir | 112.0K | $196.0K | - | |
| Dir | 112.0K | $196.0K | - | |
| Dir | 112.0K | $196.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 5,000 | $18.84 | $94,216.00 | -9.3% | |
| Aug 17, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 5,000 | $19.37 | $96,851.00 | -9.3% | |
| Jul 17, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 15,000 | $18.25 | $273,687.00 | -23.6% | |
| Jun 22, 2020 | Szela Mary T47 | Director | Sale+OE | 54,997 | $17.58 | $966,759.26 | -100% | |
| Jun 17, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $17.22 | $43,050.00 | -4.9% | |
| Jun 17, 2020 | Wahlstrom Mats66 | Director | Sell | 200,000 | $17.15 | $3,430,020.00 | -100% | |
| May 20, 2020 | Viret Jean-Frederic | Chief Financial Officer | Sell | 1,278 | $17.66 | $22,569.48 | -2.7% | |
| May 18, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 3,093 | $17.17 | $53,106.81 | -3.1% | |
| Apr 20, 2020 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 10,150 | $16.30 | $165,400.00 | -9.1% | |
| Mar 3, 2020 | Wahlstrom Mats66 | Director | Sell | 118,066 | $20.12 | $2,375,409.16 | -22.6% |